Actinium Pharmaceuticals (United States)

RPAP1, a Novel Human RNA Polymerase II-Associated Protein Affinity Purified with Recombinant Wild-Type and Mutated Polymerase Subunits

Celia Jerónimo, Marie-France Langelier, Mahel Zeghouf et al. · Molecular and Cellular Biology · 2004 · 68 citations · Full text

Phase I Trial of Targeted Alpha-Particle Therapy with Actinium-225 (225Ac)-Lintuzumab and Low-Dose Cytarabine (LDAC) in Patients Age 60 or Older with Untreated Acute Myeloid Leukemia (AML)

Joseph G. Jurcic, Moshe Levy, Jae H. Park et al. · Blood · 2016 · 53 citations

Daratumumab- ²²⁵ Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors

Wojciech Dawicki, Kevin J. Allen, Rubin Jiao et al. · OncoImmunology · 2019 · 52 citations · Full text

225Ac‐labeled CD33‐targeting antibody reverses resistance to Bcl‐2 inhibitor venetoclax in acute myeloid leukemia models

Ravendra Garg, Kevin J. Allen, Wojciech Dawicki et al. · Cancer Medicine · 2020 · 46 citations · Full text

Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 (225Ac)-Lintuzumab (Anti-CD33; HuM195) in Acute Myeloid Leukemia (AML)

Joseph G. Jurcic, Todd Rosenblat, Michael R. McDevitt et al. · Blood · 2011 · 44 citations